Nutrition GLP-1 Medications Patient Counseling

This module introduces GLP-1 receptor agonists as a class of medications increasingly used in both type 2 diabetes management and obesity treatment. It covers the key indications for GLP-1 therapy, including glycemic control in type 2 diabetes and weight management in patients with obesity or overweight conditions. The mechanism of action is explored in depth: GLP-1 receptor agonists enhance insulin secretion in a glucose-dependent manner, suppress glucagon release, slow gastric emptying, and promote satiety through central nervous system effects. These actions work together to reduce blood glucose levels and support weight loss.